Enhua Pharmaceutical H1 2026 Revenue RMB 3.218 Billion, Net Profit Up 5.74%
Enhua Pharmaceutical disclosed its semi-annual report for the first half of 2026. During the reporting period, the company generated operating revenue of RMB 3.218 billion, up 6.91% year-on-year. Net profit attributable to shareholders of the listed company reached RMB 741 million, representing a 5.74% increase from the same period last year. Basic earnings per share amounted to RMB 0.73. These financial results highlight the company's continued growth in revenue and profitability during the period.
Enhua Pharmaceutical disclosed its semi-annual report for 2026. During the reporting period, the company recorded operating revenue of RMB 3.218 billion, a year-on-year increase of 6.91%. Net profit attributable to shareholders of the listed company reached RMB 741 million, up 5.74% year-on-year. Basic earnings per share stood at RMB 0.73.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmaceuticals, with intensity 40/100 and 80% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.